Prostate Cancer | Tumor

How Theranostics Differs From the Current Prostate Cancer Treatment Options

December 1st 2020, 10:00pm


While the current field of prostate cancer research is experiencing an era of “warp speed developments,” perhaps the most exciting option on the horizon is theranostics, according to Dr. Phillip J. Koo.

FDA Approves First PET Imaging Drug for Prostate-Specific Membrane Antigen Positive Lesions in Prostate Cancer

December 1st 2020, 7:02pm


The radioactive diagnostic agent, Gallium 68 PSMA-11, can detect suspected prostate cancer metastasis or recurrence, providing another imaging option for these patients.

How Theranostics Could Impact the Future of Prostate Cancer Treatment

November 27th 2020, 2:00pm


The field of theranostics is growing, and its impact could change the future of prostate cancer treatment. CURE® discusses this potential with a theranostics expert.

FDA Approves Companion Diagnostic Device FoundationOne Liquid CDx for Patients with Prostate Cancer

November 9th 2020, 7:00pm


The FDA approved this liquid biopsy to check blood for prostate-tumor DNA that indicates the presence of genetic mutations or rearrangements. The test was also recently approved for use in patients with ovarian, non-small cell lung or breast tumors.

Understanding the Role Theranostics Plays in Treating Prostate Cancer

November 6th 2020, 7:00pm


In an interview with CURE®, Dr. Phillip J. Koo defines what theranostics is, discusses the treatment’s potential and answers questions patients may have regarding its safety.

Friday Frontline: Man Shaves Moustache for First Time in Nearly 50 Years to Raise Prostate Cancer Awareness, HGTV Star Discusses Surviving Two Cancers, and More

November 6th 2020, 4:00pm


From a Canadian man shaving his moustache for the first time in nearly 50 years to participate in Movember to HGTV’s “Flip or Flop” host Tarek El Moussa discussing his journey with testicular and thyroid cancer, here’s what’s happening in the cancer landscape this week.

Al Roker Announces Prostate Cancer Diagnosis

November 6th 2020, 3:14pm


In a candid announcement on Friday, November 6th, famed Today Show host Al Roker announced his recent prostate cancer diagnosis and prognosis.

Early Study Results Show Novel Therapy Safe, Effective in Metastatic Castration-Resistant Prostate Cancer

November 3rd 2020, 10:00pm


Treatment with a novel immuno-oncology therapy demonstrated a manageable safety profile with preliminary efficacy in patients with metastatic castration-resistant prostate cancer.

Counting My Blessings As the Wife of a Prostate Cancer Survivor

October 31st 2020, 6:00pm


As the wife of a prostate cancer survivor, I’m eternally grateful for Colorado’s early blood draw program that helped my husband get lifesaving treatment early.

With The Novel Coronavirus, Cancer Sort Of Slipped My Mind

October 22nd 2020, 4:00pm


The novel coronavirus that led to the COVID-19 pandemic has been a constant fixture, not dissimilar to how cancer hangs over our lives as well.